New grant focuses on pain, fatigue and other common, disabling, undertreated symptoms

November 20, 2014

INDIANAPOLIS -- Symptoms like pain and fatigue account for 400 million appointments with physicians annually -- 50 percent of all visits in the United States -- but have received far less attention in research, training and, consequently, patient care than many diseases. A two-year, $670,000 grant from Patient Centered Outcomes Research Institute supports a new randomized controlled study of sleep problems, pain, anxiety, depression and energy/fatigue, known as the SPADE symptom pentad.

"These five symptoms are the bread and butter of primary care but have not received much attention from the research community or enough attention from clinicians," said Regenstrief Institute investigator Kurt Kroenke, M.D., Indiana University School of Medicine Chancellor's professor of medicine and Veterans Affairs Center for Health Information and Communication investigator. The principal investigator of the SPADE study, Dr. Kroenke is an internationally respected expert in medical symptoms. He is a former president of both the Society of General Internal Medicine and the Association of Clinical Research Training.

Dr. Kroenke will conduct a new study of 300 adult primary-care patients with one or more of the SPADE symptoms -- the five most prevalent, chronic, disabling and undertreated symptoms in clinical practice. These symptoms occur frequently in most medical and mental disorders; patients often have more than one of these symptoms.

"Much of health care in the U.S. is focused on test results -- lowering blood-pressure readings, getting A1C test score for diabetics into the normal range, bringing down cholesterol levels -- but there are few quality improvement initiatives focused on symptoms," Dr. Kroenke said. "We hope that the SPADE study will tell us whether symptom measures can be valuable in clinical practice and how patients will benefit in terms of improved sleep, less fatigue and more manageable pain."

Some measurement tools for symptoms do exist, including the highly reliable PHQ-9 depression screening tool -- known as the "blood pressure cuff" for depression -- and the GAD-7 anxiety screener, both co-developed by Dr. Kroenke.

As Dr. Kroenke and colleagues investigate whether providing symptom scores to physicians improves patients' symptoms, they will involve the dual perspectives of doctor and patient. The study will be conducted in IU Health and Eskenazi Health primary-care clinics that serve a wide range of patients from diverse socioeconomic and racial/ethnic backgrounds.

"With our SPADE study, we have the opportunity to learn more about how patients can help physicians treat symptoms as well as how doctors can improve the care they provide patients with these common, disabling, undertreated symptoms," Dr. Kroenke said.

The Patient-Centered Outcomes Research Institute, which is funding the study, is a nonprofit, nongovernmental organization. Congress authorized the establishment of PCORI in the Patient Protection and Affordable Care Act of 2010.

Indiana University

Related Depression Articles from Brightsurf:

Children with social anxiety, maternal history of depression more likely to develop depression
Although researchers have known for decades that depression runs in families, new research from Binghamton University, State University of New York, suggests that children suffering from social anxiety may be at particular risk for depression in the future.

Depression and use of marijuana among US adults
This study examined the association of depression with cannabis use among US adults and the trends for this association from 2005 to 2016.

Maternal depression increases odds of depression in offspring, study shows
Depression in mothers during and after pregnancy increased the odds of depression in offspring during adolescence and adulthood by 70%.

Targeting depression: Researchers ID symptom-specific targets for treatment of depression
For the first time, physician-scientists at Beth Israel Deaconess Medical Center have identified two clusters of depressive symptoms that responded to two distinct neuroanatomical treatment targets in patients who underwent transcranial magnetic brain stimulation (TMS) for treatment of depression.

A biological mechanism for depression
Researchers report that in depressed individuals there are increased amounts of an unmodified structural protein, called tubulin, in lipid rafts compared with non-depressed individuals.

Depression in adults who are overweight or obese
In an analysis of primary care records of 519,513 UK adults who were overweight or obese between 2000-2016 and followed up until 2019, the incidence of new cases of depression was 92 per 10,000 people per year.

Why stress doesn't always cause depression
Rats susceptible to anhedonia, a core symptom of depression, possess more serotonin neurons after being exposed to chronic stress, but the effect can be reversed through amygdala activation, according to new research in JNeurosci.

Which comes first: Smartphone dependency or depression?
New research suggests a person's reliance on his or her smartphone predicts greater loneliness and depressive symptoms, as opposed to the other way around.

Depression breakthrough
Major depressive disorder -- referred to colloquially as the 'black dog' -- has been identified as a genetic cause for 20 distinct diseases, providing vital information to help detect and manage high rates of physical illnesses in people diagnosed with depression.

CPAP provides relief from depression
Researchers have found that continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA) can improve depression symptoms in patients suffering from cardiovascular diseases.

Read More: Depression News and Depression Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to